Dissent Rights Turn an Amalgamation Squeeze-Out Into Fair Value

The situation

Shira founded a precision parts supplier in Smiths Falls almost two decades ago, building it up on evenings and weekends while working full time as an elementary school teacher. When the company needed real capital to grow past a handful of employees, she brought in an investor named Kenneth, who took a majority stake and eventually became the company's controlling shareholder and chief executive. Shira stayed on the board and kept a minority holding. Her husband Herman, an IT support lead by trade, had bought a small block of shares years earlier when the company issued stock to a handful of early supporters, and the couple held their shares jointly.

Between them, Shira and Herman held about 15% of the company. Neither worked there day to day. For years that arrangement suited everyone: Kenneth ran operations, the company grew, and Shira and Herman collected the occasional dividend while getting on with their own careers.

That changed when Kenneth's holding company proposed to amalgamate the operating business into a newly formed entity he controlled, as a step toward bringing in an outside acquirer for the whole enterprise, in a deal valuing the company at somewhere between $15 million and $20 million. The amalgamation agreement set out a price for minority shares, to be paid out as the small shareholders' equity was converted into cash rather than shares in the surviving company. The price offered for Shira and Herman's combined stake came to roughly $1.9 million. Shira did the arithmetic against what she knew the company was earning and did not think that number was close to right.

What the numbers didn't add up to

An amalgamation is a legal merger of two or more companies into one surviving company, and under the Ontario Business Corporations Act it is a tool a majority shareholder can use to buy out the minority without needing every shareholder's signature on a sale. The amalgamation agreement can specify that minority common shares are converted into cash instead of shares in the company that results from the merger — a structure sometimes called a squeeze-out, because it lawfully ends a minority holder's ownership whether or not that holder agrees to sell.

The same statute that allows this also gives a shareholder who disagrees with the price a way to challenge it: the right to dissent. A dissenting shareholder rejects the amalgamation price and instead becomes entitled to be paid the fair value of their shares, determined either by agreement with the company or, failing agreement, by the Superior Court. Fair value is assessed as of the day before the shareholder vote approving the transaction, and it is meant to capture what the shares were actually worth on a going-concern basis — not a discounted figure convenient to the majority.

Shira had reason to think the $1.9 million offer undervalued the company. She had sat on the board long enough to see revenue climb steadily over several years, and she knew the price being discussed with the outside acquirer valued the whole enterprise well above what the internal squeeze-out price implied for a proportional 15% share. The company's own valuation, prepared by an advisor Kenneth had retained, applied a minority discount and a lack-of-marketability discount that, stacked together, cut the implied per-share value substantially below what an arm's-length buyer was reportedly prepared to pay for the business as a whole. Whether those discounts were appropriate for a fair value determination — as opposed to an ordinary private sale between willing parties — was exactly the kind of question the dissent process exists to test.

What we did

1. Confirmed the dissent notice and deadlines before anything else. The right to dissent is technical and unforgiving: a shareholder generally must send written objection before the vote and follow up with a formal demand for payment within a strict window after the amalgamation takes effect, or the right is lost entirely regardless of how strong the underlying valuation argument is. We checked the notice the company had sent, confirmed it met the statute's content requirements, and calendared every deadline before advising Shira and Herman on strategy, so a procedural slip never became the reason the claim failed.
2. Filed the dissent and payment demand on time, for both shareholders. Because Shira and Herman held their shares jointly, we made sure the dissent was asserted correctly for both of them as registered holders, avoiding a gap that could have let the company argue only one of them had properly dissented.
3. Retained an independent business valuator experienced in fair value determinations. Rather than argue informally over Kenneth's valuation, we commissioned a second, independent valuation built specifically around the fair value standard — a going-concern value of the company as a whole, without the minority and marketability discounts the company's valuator had applied. This gave Shira and Herman a defensible number of their own to negotiate from, not just an objection to someone else's math.
4. Used the pending acquisition talks as leverage in the analysis. The price being discussed with the outside acquirer for the entire company was directly relevant evidence of what the business was actually worth on the open market. We built that comparison into the valuation submission, showing the gap between what an arm's-length buyer was prepared to pay for the whole enterprise and what the squeeze-out price implied for a proportional minority stake.
5. Opened settlement talks before filing an application with the Superior Court. A court application to fix fair value was available once the dissent process reached an impasse, but litigating a valuation dispute through the courts typically takes a year or more and both sides usually end up paying for competing experts regardless of outcome. We used the independent valuation to press for a negotiated resolution first, making clear a court application was ready to go if the company would not move.

The outcome

Faced with a properly filed dissent, a credible independent valuation, and the obvious comparison to what the pending outside acquisition implied the company was worth, Kenneth's company came back to the table within a few months rather than let the matter proceed to a court application. The negotiated fair value for Shira and Herman's combined 15% stake settled at roughly $3.4 million — close to double the original $1.9 million squeeze-out offer, and much closer to what the independent valuator's going-concern analysis had supported.

The amalgamation itself was not undone. Kenneth's company completed its restructuring on schedule and went on to close the sale to the outside acquirer. What changed was the price Shira and Herman were paid for being taken out of the company they no longer had any way to remain part of. The gap between the original offer and the final settlement, roughly $1.5 million, reflected almost entirely the difference between a valuation built around discounts favouring the majority and one built around what the business was demonstrably worth to a buyer in the real market.

For Shira in particular, the outcome closed a chapter she had mixed feelings about. She had built the company from nothing alongside her day job, watched it grow past the point where she had much say in its direction, and ultimately lost her equity stake in a transaction she never chose to enter. Dissent rights did not let her keep her shares or her seat at the table. What they did was make sure that when the company chose to end her ownership, it had to pay what that ownership was actually worth rather than what was administratively convenient to offer.

What you can learn from this